focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 0.20 (0.82%)
Spread: 3.00 (13.043%)
Open: 24.30
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Lansdowne and Barryroe slump after licence blow

Mon, 22nd May 2023 10:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Norman Broadbent PLC, up 23% at 6.45 pence, 12-month range 3.00p-6.84p. The recruitment firm says revenue in the first quarter of 2023 jumped 67% annually to GBP2.9 million from GBP1.8 million. Net fee income rises 66% to GBP2.4 million from GBP1.5 million. Looking ahead, Norman Broadbent notes "excellent forward momentum", with a pipeline of contracted revenue at the end of the quarter of GBP2.6 million. The company expects to publish its results for 2022 later this month.

----------

Oncimmune Holdings PLC, up 9.5% to 40.41p, 12-month range 34.00p-106.09p. The immuno-diagnostics developer says it has sold its wholly-owned subsidiaries, Oncimmune Ltd and Oncimmune Europe GmbH to Freenome Holdings, for GBP13 million in cash. Oncimmune will continue to operate its ImmunoINSIGHTS business, primarily through its subsidiary Oncimmune Germany GmbH. Also says Oncimmune Germany and Freenome have signed a long-term have signed a master services agreement.

----------

AIM - LOSERS

----------

Lansdowne Oil & Gas PLC, down 56% at 0.19p, 12-month range 0.17p-0.64p; and Barryroe Offshore Energy PLC, down 42% at 1.08p, 12-month range 0.90p-4.13p. On Friday, Barryroe said a government minister in Ireland is not "satisfied with the financial capability" of those involved in an oil and gas lease application. The company, chasing a Dublin government green light for the SEL1/11 licence, said it received correspondence from Eamon Ryan, Ireland's minister for the Department of the Environment, Climate & Communications. SEL1/11 houses the Barryroe field. Barryroe Offshore owns an 80% stake in the asset, while Lansdowne Oil & Gas PLC owns 20%. On Monday, Lansdowne says it has received no direct correspondence from the Irish government department regarding the decision. However, it notes that it has verified the content directly with Barryroe. Lansdowne says that it has engaged with external legal counsel to assess its legal rights and the potential options available, including pursuing legal proceedings, for the purposes of protecting its investment in the Barryroe project.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Jul 2021 12:46

Oncimmune signs agreement with major cancer centre to profile patients

Oncimmune signs agreement with major cancer centre to profile patients

Read more
23 Jul 2021 09:44

Oncimmune inks research deal with Dana-Farber Cancer Institute

(Sharecast News) - Immunodiagnostics group Oncimmune has signed an autoantibody profiling contract with Dana-Farber Cancer Institute, based in Boston, Massachusetts, it announced on Friday.

Read more
22 Jul 2021 19:40

TRADING UPDATES: Tekcapital investee and Puma VCT 13 raise funds

TRADING UPDATES: Tekcapital investee and Puma VCT 13 raise funds

Read more
8 Jun 2021 13:11

TRADING UPDATES: Nightcap toasts sales jump after May reopening

TRADING UPDATES: Nightcap toasts sales jump after May reopening

Read more
8 Jun 2021 10:57

Oncimmune FY revenues tracking in line with expectations

(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that 2021 full-year revenues were in line with market expectations,

Read more
1 Jun 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
6 Apr 2021 16:54

IN BRIEF: Oncimmune signs separate deals with Roche and Cedars-Sinai

IN BRIEF: Oncimmune signs separate deals with Roche and Cedars-Sinai

Read more
6 Apr 2021 09:14

Oncimmune secures contracts with Roche and Cedars-Sinai

(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that it had signed two separate agreements for the use of its newly developed and proprietary Infectious Disease panel with Roche Pharmaceuticals and Cedars-Sinai Medical Center.

Read more
25 Mar 2021 16:46

Oncimmune secures GBP9 million in oversubscribed share placing

Oncimmune secures GBP9 million in oversubscribed share placing

Read more
25 Mar 2021 11:28

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

Read more
15 Feb 2021 10:30

Oncimmune Interim Loss Narrows On Higher Revenue And Lower Costs

Oncimmune Interim Loss Narrows On Higher Revenue And Lower Costs

Read more
8 Feb 2021 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
19 Jan 2021 16:30

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

Read more
14 Jan 2021 14:55

DIRECTOR DEALINGS: Oncimmune Non-Exec Cheung To Sells 195,000 Shares

DIRECTOR DEALINGS: Oncimmune Non-Exec Cheung To Sells 195,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.